Search research articles
Contact Us
Filters
Showing results (261-270 of 289) with videos related to
Page
of 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1995
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma
N M Bleehen, E S Newlands, S M Lee, et al.
Transplantation Proceedings
|
October 1, 1992
First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation
I R Hardie, D J Tiller, J F Mahony, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 29, 2007
Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes
Dag H Yasui, Sailaja Peddada, Mark C Bieda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)
R Booton, P Lorigan, H Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2009
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit
P Wheatley-Price, C Ma, L F Ashcroft, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 1995
A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma
A M Seymour, E de Campos, N Thatcher, et al.
British Journal of Cancer
|
July 1, 1988
In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients
M H Bronchud, M R Potter, G Morgenstern, et al.
British Journal of Cancer
|
August 1, 1992
Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma
S M Lee, J A Rafferty, R H Elder, et al.
Drugs
|
July 19, 2015
Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK
R Califano, N Tariq, S Compton, et al.
Oncogene
|
December 5, 1998
Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
S Vonlanthen, J Heighway, M P Tschan, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 289) with videos related to
Sort By:
Page
of 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1995
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma
N M Bleehen, E S Newlands, S M Lee, et al.
Transplantation Proceedings
|
October 1, 1992
First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation
I R Hardie, D J Tiller, J F Mahony, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 29, 2007
Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes
Dag H Yasui, Sailaja Peddada, Mark C Bieda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)
R Booton, P Lorigan, H Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 14, 2009
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit
P Wheatley-Price, C Ma, L F Ashcroft, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 1995
A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma
A M Seymour, E de Campos, N Thatcher, et al.
British Journal of Cancer
|
July 1, 1988
In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients
M H Bronchud, M R Potter, G Morgenstern, et al.
British Journal of Cancer
|
August 1, 1992
Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma
S M Lee, J A Rafferty, R H Elder, et al.
Drugs
|
July 19, 2015
Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK
R Califano, N Tariq, S Compton, et al.
Oncogene
|
December 5, 1998
Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
S Vonlanthen, J Heighway, M P Tschan, et al.
Page
of 29